Quest Diagnostics Inc. (DGX) Dividends

Quest Diagnostics Inc. (DGX): $136.68

3.70 (+2.78%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Dividend Yield and Dividend History Highlights

  • If you're seeking price stability while collecting dividends, note that DGX has less volatility in its price than 96.82% of US stocks in our dividend set.
  • Currently, DGX generates more cash flow over the 12 months prior than 85.97% of US dividend stocks.
  • As for stocks whose price is uncorrelated with DGX's price and thus may be suitable peers for a diversified dividend portfolio, check out the following: BWL.A, BGSF, UIHC, ALRM and EQC.
DGX Ex-Dividend Date
DGX Dividend Yield
1.93%
DGX Annual Dividend
$2.64
DGX Payout Ratio

DGX Price Forecast Based on Dividend Discount Model

Current PriceDDM Fair Value Target: Forecasted Gain:
$136.68$1289.06 805.49%

For dividend yielding stocks, the Dividend Discount Model (DDM) is a common valuation tool; it attempts to extrapolate a fair share price based primarily on the dividend the stock provides relative to a number of other quantiative aspects of its business. Regarding Quest Diagnostics Inc, the dividend discount model StockNews created for the company implies a positive return of 805.49%. Digging deeper, the aspects of Quest Diagnostics Inc's dividend discount model that we found most interesting were:

  • Compared to other dividend issuers in the large-sized market cap category, DGX has a beta lower than 88.16% of them.
  • Regarding its relative worth based on the dividend discount model, Quest Diagnostics Inc's estimated return of 805.49% surpasses about 89.33% of dividend issuers we applied the dividend discount model to.

DGX Dividend Chart


DGX Dividend History

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...


DGX Dividends vs. Peers

DGX's dividend yield currently ranks #3 of 86 vs. its peers in the Medical - Diagnostics/Research category.
Rank Symbol Name Dividend Yield
1 NRCIB National Research Corporation 5.00%
2 PMD Psychemedics Corporation 4.42%
3 DGX Quest Diagnostics Inc. 1.99%
4 LH Laboratory Corp. of America Holdings 1.23%
5 ABAX ABAXIS, Inc. 0.87%
6 A Agilent Technologies Inc. 0.71%
7 DHR Danaher Corp. 0.39%
8 BRKR Bruker Corporation 0.32%
9 TMO Thermo Fisher Scientific Inc. 0.22%
10 BIOC Biocept, Inc. 0.00%
11 DRIO DarioHealth Corp. 0.00%
12 NEO NeoGenomics, Inc. 0.00%
13 NEOG Neogen Corporation 0.00%
14 CNTG CENTOGENE N.V. 0.00%
15 ONVO Organovo Holdings, Inc. 0.00%
16 ICLR ICON PLC 0.00%
17 LNTH Lantheus Holdings, Inc. 0.00%
18 PRAH PRA Health Sciences, Inc. 0.00%
19 WAT Waters Corp. 0.00%
20 NSTG NanoString Technologies, Inc. 0.00%
21 OCX OncoCyte Corporation 0.00%
22 NTRA Natera, Inc. 0.00%
23 IDXG Interpace Biosciences, Inc. 0.00%
24 PRXL PAREXEL International Corporation 0.00%
25 NVDQ Novadaq Technologies Inc 0.00%
26 SYNH Syneos Health, Inc. - 0.00%
27 GENE Genetic Technologies Ltd. ADR 0.00%
28 BIO Bio-Rad Laboratories, Inc. 0.00%
29 LOGC LogicBio Therapeutics, Inc. 0.00%
30 MYNZ Mainz Biomed B.V. 0.00%
31 GHDX Genomic Health, Inc. 0.00%
32 VNRX VolitionRX Limited 0.00%
33 TROV TrovaGene, Inc. 0.00%
34 MDXH MDxHealth SA 0.00%
35 QTRX Quanterix Corporation 0.00%
36 CO Global Cord Blood Corporation 0.00%
37 NVTA Invitae Corporation 0.00%
38 CODX Co-Diagnostics, Inc. 0.00%
39 QDEL Quidel Corporation 0.00%
40 QGEN Qiagen N.V. 0.00%
41 PRE Prenetics Group Limited 0.00%
42 ANIX Anixa Biosciences, Inc. 0.00%
43 SQL SeqLL, Inc. 0.00%
44 SMLR Semler Scientific Inc. 0.00%
45 IQV IQVIA Holdings Inc. 0.00%
46 EXAS Exact Sciences Corporation 0.00%
47 OPGN OpGen, Inc. 0.00%
48 MTD Mettler-Toledo International Inc. 0.00%
49 CRL Charles River Laboratories International, Inc. 0.00%
50 OLK Olink Holding AB (publ) 0.00%
51 RDNT RadNet, Inc. 0.00%
52 CDNA CareDx, Inc. 0.00%
53 BVS Bioventus Inc. 0.00%
54 OPK OPKO Health Inc. 0.00%
55 OXFD Oxford Immunotec Global PLC - Ordinary Shares 0.00%
56 ENZ Enzo Biochem, Inc. ($0.01 Par Value) 0.00%
57 HBIO Harvard Bioscience, Inc. 0.00%
58 KANG iKang Healthcare Group, Inc. 0.00%
59 CEMI Chembio Diagnostics, Inc. 0.00%
60 PACB Pacific Biosciences of California, Inc. 0.00%
61 SRDX Surmodics, Inc. 0.00%
62 CELC Celcuity Inc. 0.00%
63 LMDX LumiraDx Limited 0.00%
64 AXDX Accelerate Diagnostics, Inc. 0.00%
65 MXCT MaxCyte, Inc. 0.00%
66 SHC Sotera Health 0.00%
67 CGIX Cancer Genetics, Inc. 0.00%
68 FLDM Fluidigm Corporation 0.00%
69 BASI Bioanalytical Systems, Inc. 0.00%
70 XGN EXAGEN INC. 0.00%
71 FLGT Fulgent Genetics, Inc. 0.00%
72 ME 23andMe Holding Co. Class A Common Stock 0.00%
73 FMI Foundation Medicine, Inc. 0.00%
74 ISPC iSpecimen Inc. 0.00%
75 VIVO Meridian Bioscience Inc. 0.00%
76 MYGN Myriad Genetics, Inc. 0.00%
77 SENS Senseonics Holdings, Inc. 0.00%
78 BEAT BioTelemetry, Inc. 0.00%
79 AKU Akumin Inc. 0.00%
80 HSKA Heska Corporation 0.00%
81 DMTK DermTech, Inc. 0.00%
82 BMRA Biomerica, Inc. 0.00%
83 BRBR BELLRING BRANDS, INC. 0.00%
84 IRTC iRhythm Technologies, Inc. 0.00%
85 HTGM HTG Molecular Diagnostics, Inc. 0.00%
86 VRML Vermillion, Inc. 0.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5884 seconds.